NEW YORK (Reuters Health) – In patients with middle cerebral artery occlusion, an alteplase dosage of 0.6 mg/kg IV is comparable to a 0.9 mg/kg dosage for achieving…
NEW YORK (Reuters Health) – Operative mortality after coronary artery bypass grafting (CABG) is higher in women, even after adjustment for preoperative risk factors, according to a study…
NEW YORK (Reuters Health) – It makes no difference whether internal tocodynamometry or external monitoring is used during induced or augmented labor – either way, the rate of…
NEW YORK (Reuters Health) – Endovascular treatment of intracranial aneurysms 3 mm or smaller in diameter is difficult and risky — but it’s successful in over 90% of…
NEW YORK (Reuters Health) – In patients with coronary shock and multivessel coronary disease, 30-day and 1-year mortality rates appear to be similar after percutaneous coronary intervention (PCI)…
NEW YORK (Reuters Health) – In an update to their 2005 recommendation, the US Preventive Services Task Force now recommends that clinicians screen children and adolescents ages 6…
NEW YORK (Reuters Health) – A single 6-mL intra-articular injection of hylan G-F 20 (Synvisc-One, Genzyme Biosurgery) safely reduces knee osteoarthritis pain for 26 weeks, results of a…
NEW YORK (Reuters Health) – More than a third of patients undergoing routine outpatient endoscopic procedures are at high risk for obstructive sleep apnea (OSA), according to findings…
NEW YORK (Reuters Health) – In diabetic patients, sirolimus-eluting stents reduce the risk for coronary artery restenosis compared with paclitaxel-eluting stents, a meta-analysis shows. Because the relative efficacy…
NEW YORK (Reuters Health) – Treatment of depression in low-income minorities with poorly controlled diabetes improved HbA1c and systolic blood pressure, investigators report in the December issue of…